PhD student at Monash University with a multidisciplinary background in nanomedicine,
molecular imaging, bioinformatics, and type 1 diabetes. Their research focuses on the early diagnosis
and treatment of diabetic kidney disease (DKD), combining nanotechnology-based drug delivery,
PET/CT imaging, and biomarker discovery. They are currently developing glucose-responsive insulin
nanoparticles and peptide-based PET imaging tools for early detection of kidney fibrosis. With
hands-on expertise in nanoparticle synthesis, small-animal models, and advanced microscopy, they
aim to translate scientific advances into clinical solutions.
For more information, please contact one of our APR.Intern Business Development Managers:
- Justin Mabbutt (VIC & TAS) – j.mabbutt@aprintern.org.au / 0413 050 952
- Mark Ovens (NSW & ACT) – m.ovens@aprintern.org.au / 0400 764 763
- Glen Sheldon – g.sheldon@aprintern.org.au / 0431 832 788
- Michael Valentine (VIC) – m.valentine@aprintern.org.au / 0411 600 063
